cdmo.directory
← Compare landing

CMC Pharmaceuticals, Inc. vs Grifols Partnership

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cmcpharm/grifols

CategoryCMC Pharmaceuticals, Inc.Grifols Partnership
Listed sitecdmocdmo
SummaryCMC Pharma provides integrated formulation development, analytical testing, stability studies, and cGMP manufacturing oversight for small molecule drug programs from preclinical through post-approval, with hands-on regulatory expertise and CMO management built in.CDMO specializing in small molecule injectable products, including concentrated and diluted parenteral formulations and intravenous solutions, leveraging 100+ years of Grifols expertise.
Services
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Technology Transfer
  • CMC Regulatory Submission Support
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Controlled Substance Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Formulation Development
  • Technology Transfer
  • CMC Regulatory Submission Support
  • API Synthesis & Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Process Development
  • Small Molecule Development & Manufacturing
  • Quality Control Testing
  • CMC Analytical Development
Modalities
  • Small Molecule
  • Biologics (Other)
  • Small Molecule
IndicationsData not yet provided.
  • Immunology
  • Neurology
  • Cardiovascular
  • Infectious Disease
  • Respiratory
Locations
  • Headquarters, Solon, Ohio, United States
  • Headquarters, Sant Cugat del Vallès, Catalonia, Spain
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.